Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.3000 (-1.85%) ($5.1000 - $5.5000) on Thu. Apr. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.99% (three month average) | RSI | 66 | Latest Price | $5.3000(-1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VXX(87%) PCY(12%) XBI(12%) LIT(10%) EWY(9%) | Factors Impacting CAPR price | CAPR will decline at least -2.995% in a week (0% probabilities). URA(-23%) IDRV(-22%) XLE(-17%) USO(-16%) BLOK(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.995% (StdDev 5.99%) | Hourly BBV | 0 () | Intraday Trend | 3.9% | | | |
|
Resistance Level | $5.7 | 5 Day Moving Average | $5.57(-4.85%) | 10 Day Moving Average | $5.68(-6.69%) | 20 Day Moving Average | $5.7(-7.02%) | To recent high | -20.3% | To recent low | 6% | Market Cap | $104m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |